<?xml version="1.0" encoding="UTF-8"?>
<ref id="B101-vaccines-07-00074">
 <label>101.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bonsignori</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Montefiori</surname>
    <given-names>D.C.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Hwang</surname>
    <given-names>K.-K.</given-names>
   </name>
   <name>
    <surname>Tsao</surname>
    <given-names>C.-Y.</given-names>
   </name>
   <name>
    <surname>Kozink</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Parks</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Tomaras</surname>
    <given-names>G.D.</given-names>
   </name>
   <name>
    <surname>Crump</surname>
    <given-names>J.A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design</article-title>
  <source>J. Virol.</source>
  <year>2012</year>
  <volume>86</volume>
  <fpage>4688</fpage>
  <lpage>4692</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.07163-11</pub-id>
  <?supplied-pmid 22301150?>
  <pub-id pub-id-type="pmid">22301150</pub-id>
 </element-citation>
</ref>
